🔎 Trials Near Me

Home › High Blood Pressure › New Jersey

High Blood Pressure clinical trials in New Jersey

9 studies for High Blood Pressure are looking for participants at sites in New Jersey.

Cities in New Jersey

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Brick
  • Clinical Trial Site, Bridgewater
  • Clinical Trial Site, Flemington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07181109

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Advanced Heart Care, LLC, Bridgewater
  • NJ Heart LLC, Linden
  • Cardio Metabolic Institute, Somerset
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07064473

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • IMA Clinical Research Warren, Warren Township
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07794579

SPYRAL GEMINI Pilot Study

  • Virtua Our Lady of Lourdes Hospital, Camden
Recruiting
Ages 18 to 80 · All sexes · Updated Oct 20, 2026 · NCT06907147

Global Paradise System US Post Approval Study

  • Virtua Health, Marlton
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT06297291

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  • The Cooper Health System, Camden
  • Virtua Medical Group, P.A., Marlton
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06059638

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • Virtua Health, Camden
  • Jersey Shore University Medical Center, Neptune City
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2026 · NCT06559891

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

  • CenExel HRI, Berlin
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07543120

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.